A New and Practical Synthetic Method for the Synthesis of 6-O-Methyl-scutellarein: One Metabolite of Scutellarin in Vivo
Scutellarin (1) has been used for the treatment of angina pectoris, cerebral infarction and coronary heart disease with a large market share in China. Pharmacokinetic studies on scutellarin showed that scutellarin (1) is readily converted into its metabolites in vivo. In this paper, a new and practi...
Main Authors: | Lin, Hang, Zhang, Wei, Dong, Ze-Xi, Gu, Ting, Li, Nian-Guang, Shi, Zhi-Hao, Kai, Jun, Qu, Cheng, Shang, Guan-Xiong, Tang, Yu-Ping, Fang, Fang, Li, He-Min, Yang, Jian-Ping, Duan, Jin-Ao |
---|---|
Format: | Online |
Language: | English |
Published: |
MDPI
2015
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4425036/ |
Similar Items
-
Comparative Metabolomic Analysis of the Neuroprotective Effects of Scutellarin and Scutellarein against Ischemic Insult
by: Tang, Hao, et al.
Published: (2015) -
Scutellarein ameliorates tongue cancer cells via mitochondria
by: Jing Guangping, et al.
Published: (2014-04-01) -
Synthesis and Bio-Activity Evaluation of Scutellarein as a Potent Agent for the Therapy of Ischemic Cerebrovascular Disease
by: Qian, Li-Hua, et al.
Published: (2011) -
Scutellarein inhibits cancer cell metastasis in vitro and attenuates the development of fibrosarcoma in vivo
by: SHI, XIUJUAN, et al.
Published: (2015) -
Scutellarein Reduces Inflammatory Responses by Inhibiting Src Kinase Activity
by: Sung, Nak Yoon, et al.
Published: (2015)